Business & Industry
Pfizer and Chai Discovery Sign AI Licensing Deal to Accelerate Drug Discovery
Pfizer has entered into a licensing agreement with Chai Discovery, granting the pharmaceutical giant access to Chai's generative AI platform for integration into its drug discovery operations. The deal provides Pfizer with early access to the newly revealed Chai-3...
Business & Industry
Eli Lilly Genetic Medicine Push Expands with Ascidian Deal
Eli Lilly has entered into a research collaboration with Ascidian Therapeutics aimed at discovering and developing treatments for kidney diseases, marking another step in the company’s ongoing genetic medicine strategy. The agreement, which could be worth up to $1.9bn for...
Business & Industry
Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool
Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant's field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi's field agents faster, more efficient...
Business & Industry
Aragen Backs Renaissance Rare Disease Therapy Launch
Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead therapeutic candidate of UK-based Renaissance Pharma Limited. The milestone marks a key step forward in...
Business & Industry
Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal
Eli Lilly has entered into a multi-program collaboration with Beijing-based Haisco Pharmaceutical Group, committing an upfront payment of $87 million and exposing itself to up to $2.97 billion in potential milestone payments. The total value of the arrangement could...
Business & Industry
Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi
Eli Lilly and Company and Hanmi Pharm have officially finalized a comprehensive licensing agreement. Under the terms of the worldwide arrangement, Sonefpeglutide licensing is for global development, manufacturing, and commercialization, excluding the South Korean market. The financial framework includes...
News
Pharmacogenomics in 2026: From Research Concept to Clinical Workflow
Pharmacogenomics has moved well beyond the research phase. In 2026, healthcare systems are using genetic insights as part of routine prescribing decisions, especially in areas such as oncology, cardiology, psychiatry, and pain management. What once sat inside academic journals...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read